indocyanine green has been researched along with Polyps in 164 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (3.66) | 29.6817 |
| 2010's | 116 (70.73) | 24.3611 |
| 2020's | 42 (25.61) | 2.80 |
| Authors | Studies |
|---|---|
| Barthelmes, D; Helbig, H; Radeck, VMM; Valmaggia, C | 1 |
| Itagaki, K; Kasai, A; Sekiryu, T; Shintake, H; Sugano, Y; Wu, H | 1 |
| Bo, Q; de Sisternes, L; Durbin, MK; Feuer, W; Gregori, G; Iyer, P; Jiang, X; Kim, K; Laiginhas, R; Lu, J; Rosenfeld, PJ; Shen, M; Shi, Y; Sun, X; Trivizki, O; Wang, F; Wang, RK; Yan, Q; Yu, SY; Zhou, H | 1 |
| Cheung, CMG; Gunatheesan, R; Lott, PW; Sim, SSKP; Sun, CZ; Teo, KYC; Vyas, CH | 1 |
| Chhablani, J; Mishra, P; Nahata, H; Reddy, NG; Venkatesh, R; Yadav, NK | 1 |
| Agarwal, A; Anantharaman, G; Bhende, M; Chawla, S; Narayanan, R; Rajendran, A; Sheth, JU | 1 |
| Gemmy Cheung, CM; Lai, TYY; Lim, TH; Margaron, P; Pataluskaite, R; Tan, CS | 1 |
| Cheung, CMG; Teo, KYC; Wong, MYZ | 1 |
| Razavi, H; Sousa, DC; Taylor, JR; Turner, AW | 1 |
| Filaly Ansary, M; Miere, A; Souied, EH | 1 |
| Jeong, A; Lee, K; Park, SH; Sagong, M; Yao, X | 1 |
| Wang, H; Xu, L; Zhang, Q; Zhang, Y | 1 |
| Honjyo, J; Itagaki, K; Matsumoto, H; Mukai, R; Sekiryu, T | 1 |
| Cheung, GCM; Tan, ACS; Yanagi, Y | 1 |
| Agard, E; De Bats, F; Dot, C; El Chehab, H; Kodjikian, L; Lagenaite-Desmaizère, C; Mathis, T | 1 |
| deCarlo, TE; Kaneko, KN; Kokame, GT; Lian, R; Omizo, JN | 1 |
| Kim, DG; Kim, ES; Kim, JM; Kim, K; Yu, SY | 1 |
| Kaneko, KN; Kokame, GT; Kokame, KA; Liu, K; Omizo, JN | 1 |
| Alex, D; Giridhar, A; Gopalakrishnan, M; Indu, VP | 1 |
| Cho, HJ; Kang, DH; Kim, JW; Kim, K; Lim, SH | 1 |
| Fujita, A; Horiguchi, E; Ito, Y; Kaneko, H; Kataoka, K; Nakano, Y; Takeuchi, J; Terasaki, H | 1 |
| Lee, K; Park, JH; Park, YG; Park, YH | 1 |
| Chia, EM; Ho, IV; Hooper, C; Hyun-Jin, HD; Liew, G; Mitchell, P; Ong, S | 1 |
| Gomi, F; Iwahashi, C; Komuku, Y | 1 |
| Chee, WK; Lim, TH; Ngo, WK; Tan, CS | 1 |
| Hirai, H; Ijuin, N; Jimura, H; Nakao, S; Nishi, T; Ogata, N; Tsujinaka, H; Ueda, T; Yamashita, M | 1 |
| Feuer, W; Gregori, G; Kim, ES; Kim, K; Rosenfeld, PJ; Yang, J; Yu, SY | 1 |
| Chakravarthy, U; Chen, SJ; Cheung, CMG; Chhablani, J; Corvi, F; Gomi, F; Gupta, V; Invernizzi, A; Jordan-Yu, JM; Kim, JE; Koh, AH; Kokame, G; Lai, TYY; Lee, WK; Mitchell, P; Ogura, Y; Ruamviboonsuk, P; Sadda, SR; Staurenghi, G; Tan, C; Teo, K; Wong, TY | 1 |
| Boon, CJF; Chung, WH; Dijkman, G; Mohabati, D; van Dijk, EHC; Veselinovic, S | 1 |
| Barreto, P; Carreira, I; Cheung, CMG; Fan, Q; Farinha, C; Gana, JC; Jordan-Yu, JM; Leopando, AK; Melo, JB; Murta, JN; Nunes, S; Silva, R; Teo, K | 1 |
| Birinci, H; Eraydin, B; Koçak, N | 1 |
| Chaudhary, N; Gandhi, A; Joshi, M; Sahu, Y | 1 |
| Chang, CJ; Chen, SJ; Hsieh, MH; Huang, YM; Li, AF | 1 |
| Atri, N; Bhatia, G; Gupta, C; Gupta, P; Shroff, CM; Shroff, D | 1 |
| Cachulo, ML; Farinha, CV; Figueira, JP; Marques, JP; Murta, JN; Nunes, S; Pires, IM; Silva, RM; Simão, JM | 1 |
| Jeong, A; Lim, J; Sagong, M | 1 |
| Bo, Q; Huang, P; Jia, H; Sun, M; Sun, X; Wang, F; Wang, H; Wang, J; Wang, Y; Xu, N; Yu, Y | 1 |
| Chakravarthy, U; Chen, SJ; Chhablani, J; Chong Teo, KY; Corvi, F; Gemmy Cheung, CM; Gomi, F; Gupta, V; Invernizzi, A; Kim, JE; Koh, AH; Kokame, G; Lai, TYY; Lee, WK; Mitchell, P; Ogura, Y; Ruamviboonsuk, P; Sadda, SR; Staurenghi, G; Tan, C; Wong, TY | 1 |
| Lim, LW; Tan, CS; Ting, DS | 2 |
| Kokame, GT; Kokame, KA; Omizo, JN; Yamane, ML | 1 |
| Kim, CG; Kim, JH; Kim, JW; Lee, DW | 1 |
| Chandra, S; Cheung, CMG; Corvi, F; Invernizzi, A; Pace, L; Sivaprasad, S; Staurenghi, G; Teo, KYC; Viola, F | 1 |
| Altomare, F; Berger, AR; Brent, MH; Chen, YN; Chow, DR; Devenyi, RG; Eng, KT; Giavedoni, LR; Kertes, PJ; Kohly, RP; Lam, WC; Muni, RH; Schwartz, CE; Soon, A; Wong, DT; Yoo, P | 1 |
| Krogh Nielsen, M; Molbech, CR; Nissen, MH; Oishi, A; Singh, A; Subhi, Y; Sørensen, TL | 2 |
| Chang, YS; Kim, CG; Kim, JH; Kim, JW; Lee, DW | 1 |
| Chen, SJ; Chen, Y; Cheung, CMG; Freund, KB; Gomi, F; Koh, AH; Lai, TYY; Lee, WK; Ruamviboonsuk, P; Wong, TY | 1 |
| Byeon, SH; Lee, J | 1 |
| Lim, LW; Lim, TH; Ngo, WK; Tan, CS | 3 |
| Li, X; Liang, S; Rosenfeld, PJ; Shi, X | 1 |
| Chen, Y; Xia, S; Zhao, X | 1 |
| Baek, J; Dansingani, KK; Freund, KB; Lee, JH; Lee, WK | 1 |
| Dahrouj, M; Oellers, P; Wu, DM | 1 |
| Liu, B; Mi, L; Peng, Y; Wen, F; Zhang, X | 1 |
| Baek, J; Cheung, CMG; Jeon, S; Lee, JH; Lee, WK | 1 |
| Bo, Q; Rosenfeld, PJ; Shen, M; Song, M; Sun, M; Sun, X; Wang, F; Yan, Q; Yu, Y | 1 |
| Bressler, NM; Chaikitmongkol, V; Patikulsila, D; Upaphong, P | 1 |
| Chhablani, J; Goud, A; Goyal, P; Parameswarappa, DC; Singh, SR | 1 |
| Eriş, E; Kocakaya, AE | 1 |
| Arndt, C; Creuzot-Garcher, C; Mauget-Faÿsse, M; Nghiem-Buffet, S; Sayag, D; Souied, E; Srour, M | 1 |
| Higuchi, M; Hikichi, T; Kitamei, H; Kosaka, S; Matsushita, R; Matsushita, T; Ohtsuka, H; Shioya, S; Takami, K | 1 |
| Chen, LJ; Chen, SJ; Chen, Y; Giridhar, A; Han Lim, T; Iida, T; Kim, H; Koh, AH; Lee, WK; Li, X; Ruamviboonsuk, P; Sharma, T; Tang, S; Yuk Yau Lai, T; Yuzawa, M | 1 |
| Iida, T; Itagaki, K; Kano, M; Saito, M | 2 |
| Jonas, JB; Wei, WB; Yang, LH | 2 |
| Gomi, F; Nishida, K; Sawa, M; Suzuki, M; Ueno, C | 1 |
| Higuchi, M; Hikichi, T; Kosaka, S; Matsushita, R; Matsushita, T; Ohtsuka, H; Takami, K | 1 |
| Baek, J; Kwon, OW; Lee, JH; Lee, MY; Lee, WK | 1 |
| Fujimura, S; Obata, R; Smith, RT; Takahashi, H; Ueta, T; Yanagi, Y | 1 |
| Cho, HJ; Kim, CG; Kim, HS; Kim, JW; Koh, KM; Lee, TG | 1 |
| Yonekawa, Y | 1 |
| Iida, T; Maruko, I; Ojima, A; Oyamada, H; Sekiryu, T; Sugano, Y | 1 |
| Haruyama, M; Kawamura, A; Mori, R; Tanaka, K; Yuzawa, M | 1 |
| Bessho, N; Fujihara, M; Honda, S; Kita, M; Kojima, H; Kurimoto, Y; Mandai, M; Matsuoka, T; Nagai, T; Negi, A; Oh, H; Oishi, A; Uenishi, M | 1 |
| Kang, HM; Koh, HJ | 2 |
| Ahn, J; Kang, SW; Kim, JH; Kim, SJ; Kim, TH | 1 |
| Cho, HJ; Han, JI; Jang, YS; Kim, CG; Kim, HS; Kim, JW; Lee, TG; Lew, YJ | 1 |
| Akiba, M; Gomi, F; Ikuno, Y; Nishida, K; Sayanagi, K | 1 |
| Kang, HM; Koh, HJ; Lee, CS; Lee, SC | 1 |
| Hwang, DJ; Kang, HM; Kim, H; Kim, YK; Lee, CS; Lee, SC; Woo, SJ | 1 |
| Kinoshita, S; Koizumi, H; Yamagishi, T; Yamazaki, T | 2 |
| Kawamura, A; Mori, R; Shinojima, A; Yuzawa, M | 1 |
| Cheung, CM; Mohla, A; Wong, TY | 1 |
| Ambati, BK; Berriochoa, Z; Fu, Y; Kumar, S | 1 |
| Chan, CM; Cheung, CM; Lim, FP; Lim, LS; Loh, BK; Wong, DW | 1 |
| Honda, S; Matsumiya, W; Miki, A; Nagai, T; Tsukahara, Y; Yanagisawa, S | 1 |
| Ijiri, S; Sugiyama, K | 1 |
| Hayashi, T; Kohno, H; Ohkuma, Y; Sakai, T; Tsuneoka, H; Watanabe, A | 1 |
| Chen, SJ; Cheung, CM; Chong, V; Htoon, H; Lai, TY; Lee, WK; Ng, WY; Ogura, Y; Wong, TY | 1 |
| Akiba, M; Gomi, F; Hara, C; Nishida, K; Sawa, M; Sayanagi, K | 1 |
| Kim, BH; Park, KH; Park, SJ; Woo, SJ | 1 |
| De Salvo, G; Keane, PA; Liew, G; Tufail, A; Vaz-Pereira, S | 1 |
| Ho, M; Liu, DT; Lo, EC; Young, AL | 1 |
| Cho, HJ; Han, SY; Kim, HS; Kim, JW; Lee, TG | 1 |
| Liu, L; Yu, Z; Zhang, J | 1 |
| Bandello, F; Casalino, G; Chakravarthy, U; Introini, U; O'Shaughnessy, D; Shusterman, EM; Slakter, JS; Triolo, G | 1 |
| Gotoh, T; Iijima, H; Kubota, T; Mabuchi, F; Nakamura, Y; Sakurada, Y; Sugiyama, A; Tateno, Y; Yoneyama, S | 1 |
| Adhi, M; Alasil, T; Baumal, CR; Brewer, E; Duker, JS; Ferrara, D; Fujimoto, JG; Hornegger, J; Kraus, MF; Reichel, E; Waheed, NK; Witkin, AJ | 1 |
| Doi, S; Fujiwara, A; Hosogi, M; Hosokawa, M; Inoue, Y; Kawata, T; Kimura, S; Matoba, R; Morizane, Y; Shiode, Y; Shiraga, F | 1 |
| Cheng, J; Cheung, CM; Lai, TY; Lee, GK; Lee, WK; Mathur, R; Wong, D; Wong, TY; Yang, E | 1 |
| Fujiwara, A; Hosogi, M; Hosokawa, M; Kawata, T; Kimura, S; Morizane, Y; Ono, A; Shiode, Y; Shiraga, F; Shiragami, C; Shirakata, Y; Yamashita, A | 1 |
| Chen, JP; Lim, TH; Ngo, WK; Tan, CS; Tan, NW | 1 |
| Gomi, F; Iwata, E; Kano, M; Maruko, R; Mori, R; Oshima, Y; Saito, M; Yamashita, A | 1 |
| Byeon, SH; Kim, H; Kim, M; Kim, SM; Kim, SS; Koh, HJ; Lee, CS; Lee, JH; Lee, SC | 1 |
| Asorey-García, A; Cifuentes-Canorea, P; Donate-López, J; Perucho-Gonzalez, L; Santos-Bueso, E | 1 |
| Byeon, SH; Kim, H; Kwon, KY; Lee, CS; Lee, JH; Lee, SC | 1 |
| Benjelloun, F; Coscas, F; Coscas, G; Dirani, A; Lupidi, M; Semoun, O; Souied, EH; Zerbib, J | 1 |
| Chung, H; Ji, B; Kim, HC; Lee, H | 1 |
| Iida, T; Kano, M; Koizumi, H; Maruko, I; Okada, AA; Saito, M; Sekiryu, T; Yamamoto, A | 1 |
| Caminiti, G; Ferrara, DC; Hughes, J; Mura, M; Peiretti, E | 1 |
| Chan, CM; Cheung, CM; Laude, A; Lim, TH; Mathur, R; Wong, D; Wong, E; Wong, TY; Wong, W | 1 |
| Cheung, GC; Lim, LS; Ting, DS; Yeo, IY | 1 |
| Balaratnasingam, C; Freund, KB; Inoue, M | 1 |
| Hariprasad, SM; Lim, TH; Tan, CS | 1 |
| Hirai, K; Kokame, GT; Yanagihara, R | 1 |
| Bukowska, DM; Chen, FK; Viljoen, RD | 1 |
| Arakawa, A; Inoue, M; Kadonosono, K; Taoka, R; Yamane, S | 1 |
| Iijima, H; Kikushima, W; Kubota, T; Mabuchi, F; Sakurada, Y; Sugiyama, A; Tanabe, N; Yoneyama, S | 1 |
| Cho, HJ; Han, JI; Kim, CG; Kim, HS; Kim, JW; Kim, KM; Lee, TG | 1 |
| Biarnés, M; Monés, J | 1 |
| Alagoz, C; Alkin, Z; Garip, R; Ozkaya, A; Perente, I; Taskapili, M; Yazici, AT | 1 |
| Lim, LW; Lim, TH; Ngo, WK; Tan, CS; Tan, NW | 1 |
| Kohno, H; Okano, K; Sakai, T; Tsuneoka, H | 1 |
| Cho, JH; Cho, KH; Park, KH; Park, SJ; Ryoo, NK; Woo, SJ | 1 |
| Andreu-Fenoll, M; Dolz-Marco, R; Gallego-Pinazo, R; García-Marín, N | 1 |
| Haga, F; Hattori, K; Ito, Y; Kaneko, H; Kataoka, K; Maruko, R; Ra, E; Sugita, T; Takayama, K; Terasaki, H | 1 |
| Kawamura, A; Mori, R; Nakashizuka, H; Tanaka, K; Wakatsuki, Y; Yuzawa, M | 1 |
| Freund, KB; Karamchandani, HK; Kotsolis, AI; Yannuzzi, LA | 1 |
| Cackett, P; Wong, D; Yeo, I | 1 |
| Chung, SE; Kang, SW; Lee, JH; Shin, WJ | 1 |
| Laude, A; Lim, TH; Tan, CS | 1 |
| Kim, IT; Park, DH | 1 |
| Ariga, H; Higuchi, M; Hikichi, T; Kosaka, S; Matsushita, R; Matsushita, T; Ohtsuka, H; Takami, K | 1 |
| Gandhi, JS; Harding, SP; Heimann, H; Nair-Sahni, J; Pournaras, CJ; Stangos, AN | 1 |
| Nakata, I; Ojima, Y; Ooto, S; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
| Gomi, F; Nishida, K; Sawa, M; Tsujikawa, M; Wakabayashi, T | 1 |
| Calabrese, A; Ciardella, AP; Missiroli, F; Regine, F; Ricci, F | 1 |
| Chang, W; Lim, S; Sagong, M | 1 |
| Harbo Bundsgaard, K; Ilginis, T; Ottosen, S; Uggerhøj Andersen, C; Vorum, H | 1 |
| Mantel, I; Schalenbourg, A; Zografos, L | 1 |
| Chen, LJ; Chen, SJ; Hashad, Y; Kim, H; Koh, A; Lai, TY; Lee, WK; Lim, TH; Pilz, S; Ruamviboonsuk, P; Tokaji, E; Weisberger, A | 1 |
| Akagi-Kurashige, Y; Miyake, M; Nakata, I; Ooto, S; Tamura, H; Tomita, K; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
| Baba, T; Kitahashi, M; Kubota-Taniai, M; Oshitari, T; Yamamoto, S | 1 |
| Jeon, S; Kim, KS; Kim, W; Lee, SB; Lee, WK | 1 |
| Cho, HJ; Cho, SW; Kim, CG; Kim, JW; Lee, DW | 1 |
| Bhargava, M; Cheung, CM; Mathur, R; Mun, CC; Wong, D; Wong, TY; Xiang, L | 1 |
| Basia, A; Ratra, D | 1 |
| Freund, KB; Goldman, DR; McCannel, CA; Sarraf, D | 1 |
| Lott, MN; Marcus, DM; Marcus, MD; Singh, H; Singh, J | 1 |
| Fujiwara, A; Shiraga, F; Shiragami, C; Shirakata, Y; Yamashita, A | 1 |
| Chan, CM; Gemmy Cheung, CM; Lee, SY; Li, X; Mathur, R; Wong, D; Wong, TY; Yeo, I | 1 |
| Chung, SE; Kang, SW; Kim, JH; Kim, YT; Park, DY | 1 |
| Kang, HM; Kim, YM; Koh, HJ | 1 |
| Christakopoulos, C; Larsen, M; Pryds, A | 1 |
| Honda, S; Kondo, N; Miki, A; Negi, A | 1 |
| Chen, C; Li, H; Wen, F; Wu, D | 1 |
| Iida, T | 1 |
4 review(s) available for indocyanine green and Polyps
| Article | Year |
|---|---|
Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.
Topics: Choroid; Choroid Diseases; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Photochemotherapy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2021 |
Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and Management.
Topics: Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Photochemotherapy; Polyps; Tomography, Optical Coherence | 2018 |
Topics: Angiogenesis Inhibitors; Choroid Diseases; Choroidal Neovascularization; Diagnostic Techniques, Ophthalmological; Fluorescein Angiography; France; Humans; Indocyanine Green; Ophthalmology; Photochemotherapy; Photosensitizing Agents; Polyps; Societies, Medical; Tomography, Optical Coherence | 2019 |
Current Management of Polypoidal Choroidal Vasculopathy.
Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Photochemotherapy; Polyps; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
10 trial(s) available for indocyanine green and Polyps
| Article | Year |
|---|---|
PREDICTORS AND IMPORTANCE OF COMPLETE POLYPOIDAL LESION REGRESSION IN THE EVEREST II STUDY: Predictors of Polyp Regression in Polypoidal Choroidal Vasculopathy.
Topics: Choroid; Choroid Diseases; Coloring Agents; Eye Diseases; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Polyps; Ranibizumab | 2022 |
EVEREST Report 5: Clinical Outcomes and Treatment Response of Polypoidal Choroidal Vasculopathy Subtypes in a Multicenter, Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Prospective Studies; Ranibizumab; Treatment Outcome; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2018 |
Photodynamic therapy versus combination therapy in polypoidal choroidal vasculopathy: changes of aqueous vascular endothelial growth factor.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Immunoassay; Indocyanine Green; Intravitreal Injections; Male; Microscopy, Confocal; Middle Aged; Photochemotherapy; Polyps; Prospective Studies; Ranibizumab; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Comparison of the effect of ranibizumab and verteporfin for polypoidal choroidal vasculopathy: 12-month LAPTOP study results.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Coloring Agents; Double-Blind Method; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
EVEREST study report 2: imaging and grading protocol, and baseline characteristics of a randomised controlled trial of polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Microscopy, Confocal; Middle Aged; Ophthalmoscopy; Polyps; Prospective Studies | 2015 |
INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prospective Studies; Ranibizumab; Retreatment; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2015 |
EVEREST study report 3: diagnostic challenges of polypoidal choroidal vasculopathy. Lessons learnt from screening failures in the EVEREST study.
Topics: Adolescent; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Diagnostic Errors; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Polyps; Porphyrins; Ranibizumab; Vascular Endothelial Growth Factor A; Verteporfin | 2016 |
EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Ranibizumab; Treatment Outcome; Verteporfin; Visual Acuity | 2012 |
Intravitreal ranibizumab for polypoidal choroidal vasculopathy in non-Asian patients.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Asian People; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Peripheral Vascular Diseases; Polyps; Prospective Studies; Ranibizumab; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
150 other study(ies) available for indocyanine green and Polyps
| Article | Year |
|---|---|
Thermal Laser Monotherapy for Extrafoveal Polypoidal Choroidal Vasculopathy.
Topics: Choroid; Choroid Diseases; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Lasers; Polyps; Retrospective Studies; Tomography, Optical Coherence; Vascular Diseases | 2021 |
The characteristics of choriocapillaris flow void in the unilateral polypoidal choroidal vasculopathy fellow eyes.
Topics: Aged; Aged, 80 and over; Area Under Curve; Case-Control Studies; Choroid; Choroidal Neovascularization; Computed Tomography Angiography; Female; Fluorescein Angiography; Humans; Indocyanine Green; Japan; Male; Middle Aged; Ophthalmoscopy; Permeability; Polyploidy; Polyps; Prevalence; Retinal Diseases; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Optical Coherence | 2021 |
Choroidal Changes in Eyes With Polypoidal Choroidal Vasculopathy After Anti-VEGF Therapy Imaged With Swept-Source OCT Angiography.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2021 |
Infographic: non-ICGA imaging for polypoidal choroidal vasculopathy (PCV) - Asia-Pacific Ocular Imaging Society PCV workgroup report 1 & 2.
Topics: Asia; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Data Visualization; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Peripheral and macular polypoidal choroidal vasculopathy: A retrospective comparative case series.
Topics: Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Updated guidelines for the management of polypoidal choroidal vasculopathy: Recommendations from the Indian Polypoidal Choroidal Vasculopathy Panel and the Vitreoretinal Society of India.
Topics: Angiogenesis Inhibitors; Choroid; Choroid Diseases; Choroidal Neovascularization; Eye Diseases; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2022 |
CHOROIDAL VASCULAR ALTERATIONS IN AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Choroid; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2023 |
Polypoidal choroidal vasculopathy in an Indigenous Australian patient.
Topics: Australia; Australian Aboriginal and Torres Strait Islander Peoples; Choroid; Choroid Diseases; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Polyp clusters: atypical presentation of polypoidal choroidal vasculopathy using OCT angiography.
Topics: Aged; Angiography; Choroid; Choroid Diseases; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Clinical implications of choroidal vascular brightness using ultra-widefield indocyanine green angiography in polypoidal choroidal vasculopathy.
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Occurrence of circumscribed choroidal hemangioma accompanied by polypoidal choroidal vasculopathy and branch retinal vein occlusion: a case report.
Topics: Aged; Choroid; Choroid Neoplasms; Choroidal Neovascularization; Fluorescein Angiography; Hemangioma; Humans; Indocyanine Green; Male; Polypoidal Choroidal Vasculopathy; Polyps; Retinal Vein Occlusion; Retinoschisis; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathy.
Topics: Choroid; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Polypoidal Choroidal Vasculopathy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2023 |
COMPARISON OF MULTICOLOR IMAGING AND COLOR FUNDUS PHOTOGRAPHY IN THE DETECTION OF PATHOLOGICAL FINDINGS IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Multimodal Imaging; Photography; Polyps; Subretinal Fluid; Tomography, Optical Coherence | 2020 |
Idiopathic polypoidal choroidal vasculopathy in Caucasians: The POLYON real-life study in 50 naive patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Polyps; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; White People | 2020 |
Anti-Vascular Endothelial Growth Factor Resistance in Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Drug Resistance; Ethnicity; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ophthalmoscopy; Polyps; Prevalence; Retrospective Studies; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2019 |
Five-Year Follow-Up of Unaffected Fellow Eyes in Patients with Polypoidal Choroidal Vasculopathy.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Incidence; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2020 |
Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration; White People | 2020 |
Lateral elongation of flat irregular pigment epithelial detachment: A novel optical coherence tomography biomarker in polypoidal choroidal vasculopathy.
Topics: Aged; Biomarkers; Choroid; Choroidal Neovascularization; Coloring Agents; Disease Progression; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence | 2020 |
Retinal pigment epithelial atrophy after anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Atrophy; Choroidal Neovascularization; Coloring Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2020 |
DIAGNOSTIC CHARACTERISTICS OF POLYPOIDAL CHOROIDAL VASCULOPATHY BASED ON B-SCAN SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY AND ITS INTERRATER AGREEMENT COMPARED WITH INDOCYANINE GREEN ANGIOGRAPHY.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Observer Variation; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2020 |
Analysis of choroidal thickness and vascularity in patients with unilateral polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Organ Size; Polyps; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |
Prevalence of polypoidal choroidal vasculopathy in Caucasian patients as estimated from optical coherence tomography signs.
Topics: Choroid; Choroid Diseases; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Prevalence; Retrospective Studies; Tomography, Optical Coherence | 2021 |
Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Photochemotherapy; Photosensitizing Agents; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2020 |
Comparing efficacy of reduced-fluence and standard-fluence photodynamic therapy in the treatment of polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Case-Control Studies; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Ranibizumab; Retina; Retrospective Studies; Subretinal Fluid; Tertiary Care Centers; Tomography, Optical Coherence; Treatment Outcome; Ultraviolet Rays; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2020 |
Clinical implications of pachyvessels in polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2020 |
A Comparison Study of Polypoidal Choroidal Vasculopathy Imaged with Indocyanine Green Angiography and Swept-Source Optical Coherence Tomography Angiography.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Polyps; Reproducibility of Results; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence | 2020 |
Polypoidal Choroidal Vasculopathy: Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup.
Topics: Aged; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnostic Techniques, Ophthalmological; Diagnostic Tests, Routine; Female; Humans; Indocyanine Green; Male; Middle Aged; Photography; Polyps; Sensitivity and Specificity; Terminology as Topic; Tomography, Optical Coherence | 2021 |
The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Polyps; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy.
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Eye Diseases; Fluorescein Angiography; Genetic Variation; Humans; Indocyanine Green; Male; Polyps; Tomography, Optical Coherence | 2021 |
The comparison of spectral domain optical coherence tomography and indocyanine green angiography in the diagnosis of polypoidal choroidal vasculopathy.
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2021 |
Flow signal change in polyps after anti-vascular endothelial growth factor therapy.
Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Regional Blood Flow; Signal Processing, Computer-Assisted; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factors | 2020 |
LONGITUDINAL SWEPT SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF EXTRAFOVEAL POLYPS AFTER COMBINATION THERAPY.
Topics: Choroid; Choroidal Neovascularization; Cross-Sectional Studies; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factors | 2022 |
Polypoidal Choroidal Vasculopathy in Caucasians: Morphological Findings from Multimodal Retinal Imaging.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2021 |
Choroidal Vascular Abnormalities by Ultra-widefield Indocyanine Green Angiography in Polypoidal Choroidal Vasculopathy.
Topics: Aged; Case-Control Studies; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2021 |
Small dome-shaped pigment epithelium detachment in polypoidal choroidal vasculopathy: an under-recognized sign of polypoidal lesions on optical coherence tomography?
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Epithelium; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Non-ICGA treatment criteria for Suboptimal Anti-VEGF Response for Polypoidal Choroidal Vasculopathy: APOIS PCV Workgroup Report 2.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Asia; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Diagnostic Techniques, Ophthalmological; Female; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Ophthalmology; Pacific States; Photochemotherapy; Photography; Polyps; Sensitivity and Specificity; Societies, Medical; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2021 |
Comparison of Polypoidal Choroidal Vasculopathy Lesion Sizes Measured on Multicolor Imaging and Indocyanine Green Angiography.
Topics: Aged; Choroid; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Prospective Studies | 2021 |
Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2021 |
LONG-TERM COURSE AND VISUAL OUTCOMES OF PRECHOROIDAL CLEFT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Angiogenesis Inhibitors; Bruch Membrane; Choroid; Choroidal Neovascularization; Coloring Agents; Extracellular Space; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retinal Pigment Epithelium; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2021 |
Multimodal Imaging Comparison of Polypoidal Choroidal Vasculopathy Between Asian and Caucasian Populations.
Topics: Choroid; Choroid Diseases; Choroidal Neovascularization; Cross-Sectional Studies; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Age-related macular degeneration: is polypoidal choroidal vasculopathy recognized and treated?
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Asian People; Canada; China; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Photochemotherapy; Polyps; Retrospective Studies; Visual Acuity; White People | 2017 |
CD11b and CD200 on Circulating Monocytes Differentiate Two Angiographic Subtypes of Polypoidal Choroidal Vasculopathy.
Topics: Aged; Antigens, CD; Biomarkers; Case-Control Studies; CD11b Antigen; Choroidal Neovascularization; Coloring Agents; Female; Flow Cytometry; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Monocytes; Polyps; Prospective Studies | 2017 |
Quantification of retinal changes after resolution of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Hemorrhage; Retinal Neurons; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
PREVALENCE AND CLINICAL CHARACTERISTICS OF PACHYDRUSEN IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Multimodal Image Study.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnostic Techniques, Ophthalmological; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Polyps; Prevalence; Retinal Drusen; Retrospective Studies; Tomography, Optical Coherence | 2019 |
Type 2 choroidal neovascularisation in polypoidal choroidal vasculopathy: a retrospective case series.
Topics: Aged; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2018 |
Characteristic appearances of fundus autofluorescence in treatment-naive and active polypoidal choroidal vasculopathy: a retrospective study of 170 patients.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Polyps; Retrospective Studies; ROC Curve; Tomography, Optical Coherence; Visual Acuity | 2018 |
CHOROIDAL MORPHOLOGY IN EYES WITH PERIPAPILLARY POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Optic Disk; Polyps; Retrospective Studies; Visual Acuity | 2019 |
Sudden-Onset Unilateral Macular Hemorrhage in a Middle-aged Man.
Topics: Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Retinal Hemorrhage; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2018 |
Multicolour imaging for the detection of polypoidal choroidal vasculopathy and age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; False Positive Reactions; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Multimodal Imaging; Photography; Polyps; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Choroidal structure in subtypes of polypoidal choroidal vasculopathy determined by binarization of optical coherence tomographic images.
Topics: Aged; Capillary Permeability; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2019 |
Polypoidal Choroidal Vasculopathy: Outer Retinal and Choroidal Changes and Neovascularization Development in the Fellow Eye.
Topics: Adult; Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Incidence; Indocyanine Green; Male; Middle Aged; Polyps; Retinal Diseases; Retinal Pigment Epithelium; Retrospective Studies; Risk Factors; Tomography, Optical Coherence | 2019 |
Appearance of Polypoidal Lesions in Patients With Polypoidal Choroidal Vasculopathy Using Swept-Source Optical Coherence Tomographic Angiography.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2019 |
OCT vs. Indocyanine Green Angiography Features of Polypoidal Choroidal Vasculopathy.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Middle Aged; Polyps; Tomography, Optical Coherence | 2018 |
Angiographic features of polypoidal choroidal vasculopathy using indocyanine green angiography and optical coherence tomography angiography: A comparative study.
Topics: Aged; Choroid; Choroidal Neovascularization; Ciliary Arteries; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Photochemotherapy; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2020 |
Comparison of optical coherence tomography angiography and green indocyanine angiography in polypoidal choroidal vasculopathy: A prospective study.
Topics: Aged; Aged, 80 and over; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Prospective Studies; Tomography, Optical Coherence | 2019 |
Polypoidal Choroidal Vasculopathy Associate With Diminished Regulatory T Cells That Are Polarized Into a T Helper 2-Like Phenotype.
Topics: Aged; Aged, 80 and over; Case-Control Studies; CD4-Positive T-Lymphocytes; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Flow Cytometry; Fluorescein Angiography; Humans; Immunophenotyping; Indocyanine Green; Interleukin-33; Interleukin-4; Male; Middle Aged; Polyps; Prospective Studies; T-Lymphocytes, Regulatory; Th2 Cells; Tomography, Optical Coherence | 2019 |
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Polyps; Prospective Studies; Ranibizumab; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Databases, Factual; Evidence-Based Medicine; Fluorescein Angiography; Humans; Indocyanine Green; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Ranibizumab; Verteporfin | 2013 |
Two-year results of combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2013 |
Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy.
Topics: Bruch Membrane; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Prospective Studies; Retinal Pigment Epithelium; Tomography, Optical Coherence; Visual Acuity | 2013 |
Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Visual Acuity | 2013 |
Factors predictive of outcomes 1 year after 3 monthly ranibizumab injections and as-needed reinjections for polypoidal choroidal vasculopathy in Japanese patients.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Asian People; Choroid Diseases; Coloring Agents; Drug Administration Schedule; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Prospective Studies; Ranibizumab; Retreatment; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Characteristics of fundus autofluorescence and drusen in the fellow eyes of Japanese patients with exudative age-related macular degeneration.
Topics: Aged; Asian People; Choroidal Neovascularization; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Japan; Male; Observer Variation; Polyps; Retinal Drusen; Wet Macular Degeneration | 2013 |
Anti-vascular endothelial growth factor monotherapy in the treatment of submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fibrinolytic Agents; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Macula Lutea; Male; Middle Aged; Photochemotherapy; Polyps; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Tissue Plasminogen Activator; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Hemorrhage | 2013 |
Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy.
Topics: Choroid; Choroid Diseases; Coloring Agents; Drug Resistance; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Middle Aged; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2013 |
Polypoidal choroidal vasculopathy in patients diagnosed with age-related macular degeneration.
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Denmark; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Polyps | 2013 |
Choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy in recurrent polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmoscopy; Organ Size; Photochemotherapy; Polyps; Ranibizumab; Recurrence; Retrospective Studies; Tomography, Optical Coherence | 2013 |
Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmoscopy; Peripheral Vascular Diseases; Polyps; Tomography, Optical Coherence | 2013 |
Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Polyps; Ranibizumab; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Five-year results of photodynamic therapy with and without supplementary antivascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2014 |
Structure of polypoidal choroidal vasculopathy studied by colocalization between tomographic and angiographic lesions.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Male; Ophthalmoscopy; Peripheral Vascular Diseases; Photochemotherapy; Polyps; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Effects of choroidal vascular hyperpermeability on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Capillary Permeability; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Comparison of spectral-domain and high-penetration OCT for observing morphologic changes in age-related macular degeneration and polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Polyps; Retina; Tomography, Optical Coherence | 2014 |
Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Lack of polypoidal lesions in patients with myopic choroidal neovascularization as evaluated by indocyanine green angiography.
Topics: Axial Length, Eye; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Myopia, Degenerative; Polyps; Recurrence; Retrospective Studies | 2014 |
Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Eye Abnormalities; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intraocular Pressure; Male; Middle Aged; Organ Size; Polyps; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2014 |
Changes in fundus autofluorescence after treatments for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Optical Imaging; Photochemotherapy; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2014 |
Morphologic features of focal choroidal excavation on spectral domain optical coherence tomography with simultaneous angiography.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Polyps; Tomography, Optical Coherence | 2014 |
Resolution of persistent pigment epithelial detachment secondary to polypoidal choroidal vasculopathy in response to Aflibercept.
Topics: Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Middle Aged; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium.
Topics: Aged; Animals; Blotting, Western; Choroidal Neovascularization; Coloring Agents; Disease Models, Animal; Female; Fluorescein Angiography; Gene Expression Regulation; High-Temperature Requirement A Serine Peptidase 1; Humans; Immunohistochemistry; Indocyanine Green; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Phenotype; Polyps; Retinal Pigment Epithelium; Serine Endopeptidases; Tomography, Optical Coherence | 2014 |
Evaluation of focal choroidal excavation in the macula using swept-source optical coherence tomography.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Polyps; Prospective Studies; Tomography, Optical Coherence; Young Adult | 2014 |
Comparison of the outcomes of photodynamic therapy between two angiographic subtypes of polypoidal choroidal vasculopathy.
Topics: Aged; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Photochemotherapy; Polyps; Retrospective Studies; Treatment Outcome; Visual Acuity | 2014 |
A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes.
Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Retrospective Studies; Verteporfin; Visual Acuity | 2014 |
Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: the group experience with digital fundus photography and confocal scanning laser ophthalmoscopy.
Topics: Aged; Area Under Curve; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Macular Degeneration; Male; Microscopy, Confocal; Ophthalmoscopy; Photography; Polyps; Prospective Studies; ROC Curve | 2014 |
En-face high-penetration optical coherence tomography imaging in polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Photochemotherapy; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence | 2015 |
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
Sensitivity and specificity of spectral-domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Choroid; Choroidal Neovascularization; Coloring Agents; False Positive Reactions; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Predictive Value of Tests; Retinal Pigment Epithelium; Retrospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence | 2014 |
Outcome of polypoidal choroidal vasculopathy at 1 year by combined therapy of photodynamic therapy with ranibizumab and predictive factors governing the outcome.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Ranibizumab; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2014 |
Factors associated with polyp regression after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retrospective Studies; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Multimodality imaging in diagnosing polypoidal choroidal vasculopathy.
Topics: Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Polyps; Tomography, Optical Coherence | 2015 |
Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Pilot Projects; Polyps; Radiosurgery; Ranibizumab; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Aqueous humor cytokine levels in patients with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Choroidal Neovascularization; Coloring Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Luminescent Measurements; Male; Polyps; Ranibizumab; Vascular Endothelial Growth Factor A; Wet Macular Degeneration | 2015 |
En face imaging of the choroid in polypoidal choroidal vasculopathy using swept-source optical coherence tomography.
Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Polyps; Prospective Studies; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A | 2015 |
Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Endotamponade; Female; Fibrinolytic Agents; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Prone Position; Prospective Studies; Retinal Hemorrhage; Tissue Plasminogen Activator; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitrectomy | 2015 |
The natural history of polypoidal choroidal vasculopathy: a multi-center series of untreated Asian patients.
Topics: Aged; Asian People; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Visual Acuity | 2015 |
Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Subretinal Fluid; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Conversion of central serous chorioretinopathy to polypoidal choroidal vasculopathy.
Topics: Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Middle Aged; Polyps; Retinal Detachment; Tomography, Optical Coherence | 2015 |
Identification of Underlying Causes of Spontaneous Submacular Hemorrhage by Indocyanine Green Angiography.
Topics: Aged; Aged, 80 and over; Aneurysm; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Polyps; Retinal Hemorrhage; Retinal Perforations; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2015 |
[Idiopathic polypoidal vasculopathy].
Topics: Diagnosis, Differential; Dilatation, Pathologic; Fluorescein Angiography; Humans; Indocyanine Green; Male; Polyps; Retinal Diseases; Retinal Vessels | 2015 |
Punctate hyperfluorescent spots associated with polypoidal choroidal vasculopathy on indocyanine green angiography.
Topics: Aged; Aged, 80 and over; Capillary Permeability; Choroid; Choroidal Neovascularization; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies | 2015 |
Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Ophthalmoscopy; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2015 |
CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Combinations; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Polyps; Ranibizumab; Retina; Retrospective Studies; ROC Curve; Statistics as Topic; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
CHOROIDAL NEOVASCULARIZATION IN CAUCASIAN PATIENTS WITH LONGSTANDING CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Polyps; Retrospective Studies; Tomography, Optical Coherence; White People | 2015 |
IMPROVED SPECIFICITY OF POLYPOIDAL CHOROIDAL VASCULOPATHY DIAGNOSIS USING A MODIFIED EVEREST CRITERIA.
Topics: Aged; Area Under Curve; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Observer Variation; Polyps; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Subretinal Fluid | 2015 |
Comparison of swept source optical coherence tomography and spectral domain optical coherence tomography in polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Prospective Studies; Retina; Tomography, Optical Coherence | 2015 |
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF POLYPOIDAL CHOROIDAL VASCULOPATHY AND POLYPOIDAL CHOROIDAL NEOVASCULARIZATION.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bruch Membrane; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Verteporfin | 2015 |
Polypoidal Choroidal Vasculopathy: Imaging by Indocyanine Green Angiography and En Face Optical Coherence Tomography.
Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Polyps; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Classification of image artefacts in optical coherence tomography angiography of the choroid in macular diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Observer Variation; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2016 |
AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY: As Needed Versus Fixed Interval Dosing.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Prospective Studies; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
GENETIC FACTORS ASSOCIATED WITH CHOROIDAL VASCULAR HYPERPERMEABILITY AND SUBFOVEAL CHOROIDAL THICKNESS IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Topics: Aged; Aged, 80 and over; Capillary Permeability; Choroid; Choroidal Neovascularization; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Gene Frequency; Genotyping Techniques; Humans; Indocyanine Green; Male; Middle Aged; Polymorphism, Single Nucleotide; Polyps; Proteins; Tomography, Optical Coherence | 2016 |
Intravitreal Aflibercept and Ranibizumab Injections for Polypoidal Choroidal Vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Direct Visualization of a New Choroidal Vessel on Spectral-Domain Optical Coherence Tomography.
Topics: Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Polyps; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2016 |
The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retinal Detachment; Retrospective Studies; Vascular Endothelial Growth Factor A; Vitelliform Macular Dystrophy; Wet Macular Degeneration | 2016 |
Three-year visual outcomes of intravitreal ranibizumab with or without photodynamic therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2016 |
Incidence Rate of Massive Submacular Hemorrhage and its Risk Factors in Polypoidal Choroidal Vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Choroidal Neovascularization; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Humans; Incidence; Indocyanine Green; Male; Polyps; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2016 |
Polypoidal choroidal vasculopathy.
Topics: Choroid Diseases; Choroidal Neovascularization; Female; Fluorescein Angiography; Fluorescent Dyes; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Polyps | 2017 |
Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Polyps; Tomography, Optical Coherence | 2017 |
Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroid Diseases; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2017 |
Hemorrhagic detachment of the posterior pole.
Topics: Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Polyps; Retinal Detachment; Retinal Hemorrhage; Visual Acuity | 2009 |
A classification system for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Peripheral Vascular Diseases; Polyps; Retrospective Studies | 2009 |
Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography.
Topics: Adult; Aged; Aged, 80 and over; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Polyps; Recurrence; Retrospective Studies; Treatment Outcome | 2009 |
Polypoidal choroidal vasculopathy: an angiographic discussion.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Fluorescein Angiography; Humans; Immunologic Factors; Indocyanine Green; Macular Degeneration; Peripheral Vascular Diseases; Photochemotherapy; Polyps; Ranibizumab; Retina; Vascular Endothelial Growth Factors | 2010 |
Asymptomatic extramacular abnormal choroidal lesions in eyes with macular polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Peripheral Vascular Diseases; Polyps; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies | 2010 |
Improvement of angiographic findings of polypoidal choroidal vasculopathy after intravitreal injection of ranibizumab monthly for 3 months.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Male; Middle Aged; Ophthalmoscopy; Peripheral Vascular Diseases; Polyps; Prospective Studies; Ranibizumab; Retreatment; Tomography, Optical Coherence; Visual Acuity; Vitreous Body | 2010 |
Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Choroidal Neovascularization; Diagnosis, Differential; Drug Resistance; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Peripheral Vascular Diseases; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2010 |
Development of polypoidal lesions in age-related macular degeneration.
Topics: Aged; Aged, 80 and over; Choroid; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Polyps; Retrospective Studies | 2011 |
Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Polyps; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prospective Studies; Ranibizumab; Retreatment; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Polyps; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Polypoidal choroidal vasculopathy in patients diagnosed with neovascular age-related macular degeneration in Denmark.
Topics: Aged; Aged, 80 and over; Choroid Diseases; Coloring Agents; Denmark; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Peripheral Vascular Diseases; Polyps; Prevalence; Visual Acuity; Wet Macular Degeneration | 2012 |
Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmoscopy; Peripheral Vascular Diseases; Polyps; Prospective Studies; Retinal Hemorrhage; Retinal Pigment Epithelium; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity | 2012 |
Factors associated with the response of age-related macular degeneration to intravitreal ranibizumab treatment.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid Diseases; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Follow-Up Studies; Genotype; Humans; Indocyanine Green; Intravitreal Injections; Male; Peripheral Vascular Diseases; Polymorphism, Single Nucleotide; Polyps; Proteins; Ranibizumab; Retrospective Studies; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Wet Macular Degeneration | 2012 |
Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroid Diseases; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Polyps; Ranibizumab; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2012 |
Responses to photodynamic therapy in patients with polypoidal choroidal vasculopathy consisting of polyps resembling grape clusters.
Topics: Aged; Aged, 80 and over; Aneurysm; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Retreatment; Retrospective Studies; Treatment Outcome; Verteporfin; Visual Acuity | 2012 |
Hemorrhagic complications after intravitreal ranibizumab injection for polypoidal choroidal vasculopathy.
Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Choroid; Choroid Diseases; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Visual Acuity; Vitrectomy | 2012 |
Six-month visual prognosis in eyes with submacular hemorrhage secondary to age-related macular degeneration or polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Photochemotherapy; Polyps; Prognosis; Prospective Studies; Retinal Hemorrhage; Time Factors; Tomography, Optical Coherence; Visual Acuity; Wet Macular Degeneration | 2013 |
Intravitreous tissue plasminogen activator with pneumatic displacement in submacular hemorrhage.
Topics: Choroid Diseases; Coloring Agents; Female; Fibrinolytic Agents; Fluorescein Angiography; Fluorocarbons; Humans; Indocyanine Green; Intravitreal Injections; Middle Aged; Polyps; Retinal Hemorrhage; Supine Position; Tissue Plasminogen Activator | 2012 |
Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes.
Topics: Aged; Aged, 80 and over; Choroid Diseases; Choroid Hemorrhage; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Peripheral Vascular Diseases; Polyps; Retinal Hemorrhage; Retrospective Studies; Tomography, Optical Coherence | 2013 |
Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Laser Therapy; Male; Middle Aged; Peripheral Vascular Diseases; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Prospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroid Diseases; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Indocyanine Green; Intravitreal Injections; Laser Therapy; Lasers, Excimer; Male; Middle Aged; Polyps; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |
Engorgement of vortex vein and polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Polyps; Tomography, Optical Coherence; Varicose Veins | 2013 |
Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
Topics: Aged; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Polyps; Porphyrins; Recurrence; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Subretinal lamellar bodies in polypoidal choroidal vasculopathy.
Topics: Aged; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Inclusion Bodies; Indocyanine Green; Photochemotherapy; Polyps; Retinal Pigment Epithelium; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2013 |
The association of age-related maculopathy susceptibility 2 (ARMS2) and complement factor H (CFH) variants with two angiographic subtypes of polypoidal choroidal vasculopathy.
Topics: Aged; Aged, 80 and over; Choroid; Choroid Diseases; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Gene Frequency; Genotyping Techniques; Humans; Indocyanine Green; Male; Middle Aged; Phenotype; Polymorphism, Single Nucleotide; Polyps; Proteins; Visual Acuity | 2013 |
Polypoidal choroidal vasculopathy in elderly Chinese patients.
Topics: Age Distribution; Aged; Aged, 80 and over; Angiography; Asian People; China; Choroid; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Incidence; Indocyanine Green; Male; Middle Aged; Peripheral Vascular Diseases; Polyps; Retrospective Studies | 2004 |
[Diagnostic criteria for polypoidal choroidal vasculopathy and their clinical significance].
Topics: Choroid; Choroid Diseases; Fluorescein Angiography; Humans; Indocyanine Green; Peripheral Vascular Diseases; Polyps; Reference Standards | 2005 |
[Criteria for diagnosis of polypoidal choroidal vasculopathy].
Topics: Choroid; Choroid Diseases; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Peripheral Vascular Diseases; Polyps; Reference Standards | 2005 |